170 related articles for article (PubMed ID: 18535474)
1. Blister fluid composition in a pediatric patient with toxic epidermal necrolysis.
Gandhi M; Kowal-Vern A; An G; Hanumadass M
J Burn Care Res; 2008; 29(4):671-5. PubMed ID: 18535474
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC
J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470
[TBL] [Abstract][Full Text] [Related]
3. Variable levels of apoptotic signal-associated cytokines in the disease course of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yang Y; Li F; Du J; Shen Y; Lin J; Zhu X; Luo X; Liang J; Xu J
Australas J Dermatol; 2017 Aug; 58(3):e61-e67. PubMed ID: 27040133
[TBL] [Abstract][Full Text] [Related]
4. Proteomic kinetic analysis of blister fluid and serum in a patient with drug-induced toxic epidermal necrolysis. A comparison with skin immunohistochemistry.
Paquet P; Meuwis MA; Mazzucchelli G; Delvenne P; Piérard GE
Curr Drug Saf; 2012 Nov; 7(5):339-51. PubMed ID: 23373548
[TBL] [Abstract][Full Text] [Related]
5. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
[TBL] [Abstract][Full Text] [Related]
6. Crystal-clear blister fluid with low albumin concentration during toxic epidermal necrolysis.
Contou D; Flores-Paraire L; Ortonne N; Chosidow O; de Prost N
Burns; 2016 Sep; 42(6):1360-1. PubMed ID: 27338179
[No Abstract] [Full Text] [Related]
7. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
[TBL] [Abstract][Full Text] [Related]
8. Blister fluid cytokines in cutaneous inflammatory bullous disorders.
Rhodes LE; Hashim IA; McLaughlin PJ; Friedmann PS
Acta Derm Venereol; 1999 Jul; 79(4):288-90. PubMed ID: 10429986
[TBL] [Abstract][Full Text] [Related]
9. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
Guleria VS; Sharda C; Rana T; Sood AK
Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
[TBL] [Abstract][Full Text] [Related]
10. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis.
Correia O; Delgado L; Barbosa IL; Campilho F; Fleming-Torrinha J
J Am Acad Dermatol; 2002 Jul; 47(1):58-62. PubMed ID: 12077582
[TBL] [Abstract][Full Text] [Related]
12. Response to Letter to the Editor: 'Crystal-clear blister fluid with low albumin concentration during toxic epidermal necrolysis'.
Lim VM; Grossman R
Burns; 2016 Sep; 42(6):1361-2. PubMed ID: 27325217
[No Abstract] [Full Text] [Related]
13. Energy requirements of pediatric patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Mayes T; Gottschlich M; Khoury J; Warner P; Kagan R
Nutr Clin Pract; 2008; 23(5):547-50. PubMed ID: 18849560
[TBL] [Abstract][Full Text] [Related]
14. Phenytoin induced toxic epidermal necrolysis.
Topcu H; Gokcinar D; Akcaboy ZN; Karabeyoglu I; Unal T
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S267-9. PubMed ID: 25518798
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.
Correia O; Delgado L; Roujeau JC; Le Cleach L; Fleming-Torrinha JA
Arch Dermatol; 2002 Jan; 138(1):29-32. PubMed ID: 11790164
[TBL] [Abstract][Full Text] [Related]
16. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis.
Paquet P; Ribbens C; Piérard GE
Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
Poletti-Jabbour J; Wiegering-Rospigliosi A; Pereyra-Elías R; Elías-Barrera CC
Eur J Clin Pharmacol; 2016 Aug; 72(8):1031-2. PubMed ID: 27130345
[No Abstract] [Full Text] [Related]
18. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
19. [Severe drug-related skin reaction: toxic epidermal necrolysis caused by carbamazepine].
Fischer M; Hamm H; Wirbelauer J
Klin Padiatr; 2004; 216(5):288-93. PubMed ID: 15455296
[TBL] [Abstract][Full Text] [Related]
20. Are carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis more common in nonepileptic patients?
Dhar S; Todi SK
Dermatology; 1999; 199(2):194. PubMed ID: 10559602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
